158 related articles for article (PubMed ID: 34649021)
41. mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients.
Albiol N; Aso O; Gómez-Pérez L; Triquell M; Roch N; Lázaro E; Esquirol A; González I; López-Contreras J; Sierra J; Martino R; García-Cadenas I
Support Care Cancer; 2022 Dec; 30(12):9687-9690. PubMed ID: 36169731
[TBL] [Abstract][Full Text] [Related]
42. SARS-CoV-2 in saliva, viremia and seroprevalence for COVID-19 surveillance at a single hematopoietic stem cell transplantation center: a prospective cohort study.
Mobile RZ; Warnawin SVSC; Kojo TK; Rodrigues JAP; Cavilha AMQ; Zerbinati RM; Adamoski D; Oliveira JC; Conzentino MS; Huergo LF; Gradia DF; Braz-Silva PH; Schussel JL
Rev Inst Med Trop Sao Paulo; 2022; 64():e39. PubMed ID: 35674637
[TBL] [Abstract][Full Text] [Related]
43. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients.
Malek AE; Adachi JA; Mulanovich VE; Sassine J; Raad II; McConn K; Seiler GT; Dhal U; Khawaja F; Chemaly RF
Transpl Infect Dis; 2021 Aug; 23(4):e13606. PubMed ID: 33755273
[TBL] [Abstract][Full Text] [Related]
44. Liver or Kidney Transplantation After SARS-CoV-2 Infection: Prevalence, Short-term Outcome, and Kinetics of Serum IgG Antibodies.
Verbeek J; Vrij C; Vermeersch P; Van Elslande J; Vets S; Lagrou K; Vos R; van Cleemput J; Jochmans I; Monbaliu D; Pirenne J; Kuypers D; Nevens F
Transplantation; 2022 Apr; 106(4):862-868. PubMed ID: 34534192
[TBL] [Abstract][Full Text] [Related]
45. Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Brunner AM; Kim HT; Coughlin E; Alyea EP; Armand P; Ballen KK; Cutler C; Dey BR; Glotzbecker B; Koreth J; McAfee SL; Spitzer TR; Soiffer RJ; Antin JH; Ho VT; Chen YB
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1374-80. PubMed ID: 23791626
[TBL] [Abstract][Full Text] [Related]
46. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients.
Bird PW; Badhwar V; Kennedy B; Ladani S; Tang JW
J Med Virol; 2021 Jul; 93(7):4585-4591. PubMed ID: 33595119
[TBL] [Abstract][Full Text] [Related]
47. Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients.
Easdale S; Shea R; Ellis L; Bazin J; Davis K; Dallas F; Thistlethwayte E; Ethell M; Potter M; Arias C; Anthias C; Nicholson E
Transplant Cell Ther; 2021 Oct; 27(10):880.e1-880.e4. PubMed ID: 34293520
[TBL] [Abstract][Full Text] [Related]
48. Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.
Shumilov E; Shakhanova I; Flach J; Schmidt N; Buerki S; Legros M; Kronig MN; Ofran Y; Gerull S; Medinger M; Taleghani BM; Passweg J; Halter J; Bacher U; Pabst T
Bone Marrow Transplant; 2022 Feb; 57(2):224-231. PubMed ID: 34775480
[TBL] [Abstract][Full Text] [Related]
49. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort.
Gao H; Wang J; Zheng X; Pei X; Zheng Y; Zhai W; Zhang R; Chen X; Ma Q; Wei J; Yang D; Pang A; He Y; Feng S; Cao Y; Jiang E
Front Cell Infect Microbiol; 2024; 14():1324019. PubMed ID: 38505288
[TBL] [Abstract][Full Text] [Related]
50. Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East.
El Fakih R; Haroon A; Alfraih F; Al-Khabori MK; Alzahrani M; Alhuraiji A; Hamadah A; AlJohani NI; Alahmari B; Essa MF; Motabi IH; Tailor IK; Almaghrabi RS; Al-Farsi K; Abosoudah I; Ayas M; Elhassan TA; Suhebeh AM; Ahmed SO; Alhayli S; Kaloyannidis P; Alsaeed A; Anezi KA; Alamoudi S; Damlaj M; Hashmi HA; Aljurf M
Bone Marrow Transplant; 2021 Sep; 56(9):2144-2151. PubMed ID: 33907304
[TBL] [Abstract][Full Text] [Related]
51. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
[TBL] [Abstract][Full Text] [Related]
52. Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study.
Munshi L; Darmon M; Soares M; Pickkers P; Bauer P; Meert AP; Martin-Loeches I; Staudinger T; Pene F; Antonelli M; Barratt-Due A; Demoule A; Metaxa V; Lemiale V; Taccone F; Mokart D; Azoulay E; Mehta S;
Transplant Cell Ther; 2021 Jan; 27(1):78.e1-78.e6. PubMed ID: 33011289
[TBL] [Abstract][Full Text] [Related]
53. Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Connor MP; Loren AW; Hexner EO; Martin ME; Gill SI; Luger SM; Mangan JK; Perl AE; McCurdy SR; Pratz KW; Timlin C; Freyer CW; Carulli A; Catania C; Smith J; Hollander L; Zebrowski AM; Stadtmauer EA; Porter DL; Frey NV
Transplant Cell Ther; 2023 Feb; 29(2):113-118. PubMed ID: 36336258
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract][Full Text] [Related]
55. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
56. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
Piñana JL; Martino R; Vazquez L; López-Corral L; Pérez A; Chorão P; Avendaño-Pita A; Pascual MJ; Sánchez-Salinas A; Sanz-Linares G; Olave MT; Arroyo I; Tormo M; Villalon L; Conesa-Garcia V; Gago B; Terol MJ; Villalba M; Garcia-Gutierrez V; Cabero A; Hernández-Rivas JÁ; Ferrer E; García-Cadenas I; Teruel A; Navarro D; Cedillo Á; Sureda A; Solano C;
Bone Marrow Transplant; 2023 May; 58(5):567-580. PubMed ID: 36854892
[TBL] [Abstract][Full Text] [Related]
57. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
[TBL] [Abstract][Full Text] [Related]
58. Successful second outpatient autologous hematopoietic cell transplant for relapsed POEMS syndrome in a patient with coexisting HIV, HBV and syphilis infections during the COVID-19 pandemic.
Hernández-Coronado M; Jaime-Pérez JC; Villarreal-Martínez A; Ocampo-Candiani J; Gómez-Almaguer D
Transpl Immunol; 2021 Aug; 67():101412. PubMed ID: 34020046
[TBL] [Abstract][Full Text] [Related]
59. High Seroconversion Rate Against Severe Acute Respiratory Syndrome Coronavirus 2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.
Ruan W; Nguyen H; Wyatt A; Ihekweazu F; Vartabedian BS; Karam L; Walsh S; Kellermayer R
J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):363-366. PubMed ID: 34173793
[TBL] [Abstract][Full Text] [Related]
60. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
